We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Lipid Profiling of Blood Samples Reveals Biomarkers for Cardiometabolic Disease Risk

By LabMedica International staff writers
Posted on 29 Apr 2022
Print article
Image: Lipidomics provides new biomarkers for cardiovascular disease and Type II diabetes (Photo courtesy of DIfE)
Image: Lipidomics provides new biomarkers for cardiovascular disease and Type II diabetes (Photo courtesy of DIfE)

A lipidomics-based analysis of plasma samples from a large cohort of participants identified several lipids associated with cardiometabolic disease risk that might serve as biomarkers for diagnosis of cardiovascular disease and Type II diabetes.

Lipidomics is the large-scale study of pathways and networks of cellular lipids in biological systems. The word "lipidome" is used to describe the complete lipid profile within a cell, tissue, organism, or ecosystem and is a subset of the "metabolome" which also includes the three other major classes of biological molecules: proteins/amino-acids, sugars, and nucleic acids. Lipidomics is a relatively recent research field that has been driven by rapid advances in technologies such as mass spectrometry (MS), nuclear magnetic resonance (NMR) spectroscopy, fluorescence spectroscopy, dual polarization interferometry, and computational methods coupled with the recognition of the role of lipids in many metabolic diseases such as obesity, atherosclerosis, stroke, hypertension, and diabetes.

Cardiovascular disease is the leading cause of death worldwide, accounting for around 18 million deaths per year. People with Type II diabetes have a two- to threefold increased risk of suffering a heart attack or stroke. Accordingly, there is a great need to identify biomarkers that can indicate the development of disease at an early stage in order to prevent or at least mitigate its onset.

In this regard, investigators at the German Institute of Human Nutrition (DifE) of the German Center for Diabetes Research (Deutsches Zentrum fuer Diabetesforschung) evaluated the fatty acid profiles in 2,414 blood samples from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. The samples were collected as early as the 1990s and in part came from participants who developed cardiovascular disease or Type II diabetes in subsequent years.

Using high-throughput lipidomics, the investigators identified a total of 282 different lipids, 69 of which were associated with at least one of the two diseases. Several monoacylglycerols and 16 and 18 chain fatty acids in diacylglycerols were associated with both outcomes. Cholesteryl esters, free fatty acids, and sphingolipids were largely cardiovascular disease-specific, while several (glycero)phospholipids were Type II diabetes-specific.

First author Dr. Fabian Eichelmann, a researcher in the department of molecular epidemiology at the German Institute of Human Nutrition and at the German Center for Diabetes Research, said, "A statistical association with cardiovascular diseases was found for 49 lipids, which mainly belonged to the cholesterol esters and sphingolipids. Twelve lipids were associated with Type II diabetes, the majority of which were glycerol and phospholipids. An association with both diseases was seen for eight lipids, among which several monoacylglycerides stood out."

The study was published in the April 15, 2022, online edition of the journal Circulation.

Related Links:
German Institute of Human Nutrition 
German Center for Diabetes Research 

 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.